DGAP-News: OHB AG / Key word(s): Miscellaneous OHB AG: The OHB AG publishes preliminary and unaudited results for the previous fiscal year 2013 and offers a first outlook on the business development in 2014 25.02.2014 / 10:30 --------------------------------------------------------------------- The OHB AG publishes preliminary and unaudited results for the previous fiscal year 2013 and offers a first outlook on the business development in 2014: - Total revenues 2013 climbing up to EUR 700 million (+ 11%) - EBITDA 2013 increases to EUR 52 million (+ 13%) - EBIT 2013 increases to EUR 36 million (+ 16%) Further growth is expected for the current fiscal year: - Total revenues 2014 are expected to increase to more than EUR 750 million (+ 7%) - EBITDA 2014 will reach more than EUR 56 million (+ 8%) - EBIT 2014 will reach more than EUR 39 million (+ 8%) Bremen, February 25, 2014. On the occasion of today's annual Capital Market Day of the Group, the management board of the OHB AG (Prime Standard, ISIN: DE0005936124) offers a first outlook on the current fiscal year 2014 on the basis of the three following ratios: Total revenues will increase to more than EUR 750 million, EBITDA and EBIT will reach more than EUR 56 million, respectively more than EUR 39 million. This positive outlook is due to the high order backlog of EUR 2.3 billion, that will secure a high workload for the subsidiaries of OHB AG for the years to come. Consolidated total revenues for the previous fiscal year will presumably climb up to EUR 700 million, EBITDA will presumably increase to EUR 52 million and EBIT is expected to come to EUR 36 million in 2013. With these ratios OHB will reach the guidance that was published by the management board in February 2013. OHB AG's audited consolidated financial statements for 2013 will be presented in detail at the upcoming annual press conference in Bremen, on March 20th, 2014 and at the analyst conference held afterwards on the same day in Frankfurt am Main. Contact: Martina Lilienthal Investor Relations Tel.: +49 (0)421 - 2020-720 Fax: +49 (0)421 - 2020-613 E-Mail: martina.lilienthal@ohb.de www.ohb.de End of Corporate News --------------------------------------------------------------------- 25.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: OHB AG Karl-Ferdinand-Braun-Str. 8 28359 Bremen Germany Phone: +49 (0)421 2020 8 Fax: +49 (0)421 2020 613 E-mail: ir@ohb.de Internet: www.ohb.de ISIN: DE0005936124 WKN: 593612 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 254097 25.02.2014
DGAP-News: OHB AG: The OHB AG publishes preliminary and
Top 10 Most Recent News Articles
PenFed Credit Union's Soaring Loan Originations in Q3 2026
Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...
Continue Reading
AstroRad Vest Makes Spaceflight History at Smithsonian
Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...
Continue Reading
Cooper's Stock Takes a Beating: What's Behind It?
A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...
Continue Reading
Green Methanol: A $20.11B Market by 2032 Excites
The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...
Continue Reading
Del Monte Faces Class Action Over Major Data Breach
Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...
Continue Reading
Cytrellis Boosts Aesthetics Training With Miami Partnership
Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...
Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights
BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...
Continue Reading
SCI Faces Investigation After Earnings Downgrade
SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....
Continue Reading
Intestinal Worms: New Science and Old Challenges
Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...
Continue Reading
Gastops and Bell: A New Era in Aerospace Collaboration
Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...
Continue ReadingTop 5 Most Recently Viewed Articles
Vitesse Energy's Q3 Performance and Future Prospects Examined
Vitesse Energy's Third Quarter Highlights Vitesse Energy, Inc. (NYSE: VTS) recently shared its financial and operating results for the third quarter. The company reported a robust net income of $17.4 million alongside an adjusted net income of $7.6 million. The adjusted EBITDA reached $37.6 million, alongside operational cash flow exceeding $45.7 million, showcasing a...
Continue Reading
Capital One Financial Soars After Impressive Third-Quarter Gains
Capital One's Remarkable Q3 Performance Capital One Financial Corp. (NYSE: COF) recently unveiled its third-quarter results, showcasing a strong financial performance that exceeded analysts' expectations. The report highlighted significant increases in both earnings and revenue, making a substantial impact on investor confidence and stock performance. Diving into the Key...
Continue Reading
Recent Developments Boost Travere Therapeutics' Market Outlook
Update on Travere Therapeutics On a recent Wednesday, Stifel maintained its Hold rating for Travere Therapeutics (NASDAQ:TVTX) while raising the price target to $13.00 from the previous $10.00. This adjustment is a result of a thorough analysis of the company's recent progress, specifically focusing on their drug candidate, Sparsentan. Significance of the PARASOL Workshop...
Continue Reading
Kahoot! Achieves Gold Certification in Educational Equity
Kahoot! Achieves Gold Certification in Educational Equity Kahoot!, the renowned education technology platform, has recently been awarded the prestigious ICEIE Gold certification for its unwavering commitment to equity in education. This recognition emphasizes the company's dedication to ensuring that all learners have access to quality educational tools and resources,...
Continue Reading
Spicewood Mineral Partners Expands Holdings with New Acquisitions
Spicewood Mineral Partners Expands Holdings in the Permian Basin Spicewood Mineral Partners, a prominent mineral and energy investment firm based in Dallas, has made exciting updates regarding its latest acquisitions in the Delaware Basin. The company has recently targeted a selection of high-quality "tier 1" mineral assets in the Permian Basin, showcasing a strategic...
Continue Reading